
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prostate cancer patient‐derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens
Raphaëlle Servant, Michele Garioni, Tatjana Vlajnic, et al.
The Journal of Pathology (2021) Vol. 254, Iss. 5, pp. 543-555
Open Access | Times Cited: 58
Raphaëlle Servant, Michele Garioni, Tatjana Vlajnic, et al.
The Journal of Pathology (2021) Vol. 254, Iss. 5, pp. 543-555
Open Access | Times Cited: 58
Showing 26-50 of 58 citing articles:
Engineering prostate cancer in vitro: what does it take?
Adriana Buskin, Emma Scott, Ryan Nelson, et al.
Oncogene (2023) Vol. 42, Iss. 32, pp. 2417-2427
Open Access | Times Cited: 7
Adriana Buskin, Emma Scott, Ryan Nelson, et al.
Oncogene (2023) Vol. 42, Iss. 32, pp. 2417-2427
Open Access | Times Cited: 7
Organoids of the male reproductive system: Challenges, opportunities, and their potential use in fertility research
Daniela Patrício, Joana Santiago, João F. Mano, et al.
WIREs Mechanisms of Disease (2022) Vol. 15, Iss. 2
Open Access | Times Cited: 12
Daniela Patrício, Joana Santiago, João F. Mano, et al.
WIREs Mechanisms of Disease (2022) Vol. 15, Iss. 2
Open Access | Times Cited: 12
A systematic review of patient-derived tumor organoids generation from malignant effusions
Sofie Seghers, Maxim Le Compte, Jeroen Hendriks, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 195, pp. 104285-104285
Closed Access | Times Cited: 2
Sofie Seghers, Maxim Le Compte, Jeroen Hendriks, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 195, pp. 104285-104285
Closed Access | Times Cited: 2
Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients
Giada De Lazzari, Alena Opattová, Sabrina Arena
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Giada De Lazzari, Alena Opattová, Sabrina Arena
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
The future of cancer therapy: exploring the potential of patient-derived organoids in drug development
Çığır Biray Avcı, Bakiye Göker Bağca, Behrouz Shademan, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Çığır Biray Avcı, Bakiye Göker Bağca, Behrouz Shademan, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Exploring tumor organoids for cancer treatment
Hairong Jin, Qian Yang, Jing Yang, et al.
APL Materials (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 2
Hairong Jin, Qian Yang, Jing Yang, et al.
APL Materials (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 2
Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signaling
Erika Héninger, David Kosoff, Tamara S. Rodems, et al.
Medical Oncology (2021) Vol. 38, Iss. 11
Open Access | Times Cited: 14
Erika Héninger, David Kosoff, Tamara S. Rodems, et al.
Medical Oncology (2021) Vol. 38, Iss. 11
Open Access | Times Cited: 14
Application of Organoid Models in Prostate Cancer Research
Ligui Zhou, Caiqin Zhang, Yongbin Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 14
Ligui Zhou, Caiqin Zhang, Yongbin Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 14
Patient-derived organoids as a model for tumor research
Jia Wang, Xiaoying Feng, Zhichao Li, et al.
Progress in molecular biology and translational science (2022), pp. 259-326
Closed Access | Times Cited: 8
Jia Wang, Xiaoying Feng, Zhichao Li, et al.
Progress in molecular biology and translational science (2022), pp. 259-326
Closed Access | Times Cited: 8
Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling
Annelies Van Hemelryk, Ingrid Tomljanović, Corrina M.A. de Ridder, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3632-3632
Open Access | Times Cited: 8
Annelies Van Hemelryk, Ingrid Tomljanović, Corrina M.A. de Ridder, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3632-3632
Open Access | Times Cited: 8
New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine
Vittoria Rago, Anna Perri, Silvia Di Agostino
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2743-2743
Open Access | Times Cited: 4
Vittoria Rago, Anna Perri, Silvia Di Agostino
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2743-2743
Open Access | Times Cited: 4
Urological cancer organoids, patients' avatars for precision medicine: past, present and future
Haotian Chen, Wentao Zhang, Niraj Maskey, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Haotian Chen, Wentao Zhang, Niraj Maskey, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Tumor Organoids as a Research Tool: How to Exploit Them
Tijmen H. Booij, Chiara Cattaneo, Christian Hirt
Cells (2022) Vol. 11, Iss. 21, pp. 3440-3440
Open Access | Times Cited: 7
Tijmen H. Booij, Chiara Cattaneo, Christian Hirt
Cells (2022) Vol. 11, Iss. 21, pp. 3440-3440
Open Access | Times Cited: 7
Defining the challenges and opportunities for using patient‐derived models in prostate cancer research
W. Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna, et al.
The Prostate (2024) Vol. 84, Iss. 7, pp. 623-635
Open Access | Times Cited: 1
W. Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna, et al.
The Prostate (2024) Vol. 84, Iss. 7, pp. 623-635
Open Access | Times Cited: 1
Targeting the cancer cells and cancer‐associated fibroblasts with next‐generation FGFR inhibitors in prostate cancer co‐culture models
Syeda Afshan, Yu Gang Kim, Jesse Mattsson, et al.
Cancer Medicine (2024) Vol. 13, Iss. 18
Open Access | Times Cited: 1
Syeda Afshan, Yu Gang Kim, Jesse Mattsson, et al.
Cancer Medicine (2024) Vol. 13, Iss. 18
Open Access | Times Cited: 1
ECM-free patient-derived organoids preserve diverse prostate cancer lineages and uncover in vitro-enriched cell types
Robin Dolgos, Romuald Parmentier, Jing Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Robin Dolgos, Romuald Parmentier, Jing Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The first experience of using prostate cancer organoids as a model for personalized selection of drugs
С. В. Никулин, B. Yа. Alekseev, А. А. Полозников, et al.
Cancer Urology (2023) Vol. 19, Iss. 2, pp. 41-46
Open Access | Times Cited: 3
С. В. Никулин, B. Yа. Alekseev, А. А. Полозников, et al.
Cancer Urology (2023) Vol. 19, Iss. 2, pp. 41-46
Open Access | Times Cited: 3
Three Dimensional Models of Endocrine Organs and Target Tissues Regulated by the Endocrine System
Edlira Luca, Kathrin Zitzmann, Stefan R. Bornstein, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4601-4601
Open Access | Times Cited: 3
Edlira Luca, Kathrin Zitzmann, Stefan R. Bornstein, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4601-4601
Open Access | Times Cited: 3
Advantages and limitations of 3D organoids and ex vivo tumor tissue culture in personalized medicine for prostate cancer
Alena Mičková, Martin Morong, Monika Levková, et al.
Klinicka onkologie (2022) Vol. 35, Iss. 6
Open Access | Times Cited: 3
Alena Mičková, Martin Morong, Monika Levková, et al.
Klinicka onkologie (2022) Vol. 35, Iss. 6
Open Access | Times Cited: 3
Clinicopathological Factors as Predictors for Establishment of Patient Derived Head and Neck Squamous Cell Carcinoma Organoids
W. W. B. de Kort, R. Millen, E. Driehuis, et al.
Head and Neck Pathology (2024) Vol. 18, Iss. 1
Open Access
W. W. B. de Kort, R. Millen, E. Driehuis, et al.
Head and Neck Pathology (2024) Vol. 18, Iss. 1
Open Access
Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine
Jelena Dinić, Sofija Jovanović Stojanov, Miodrag Dragoj, et al.
Life (2024) Vol. 14, Iss. 9, pp. 1142-1142
Open Access
Jelena Dinić, Sofija Jovanović Stojanov, Miodrag Dragoj, et al.
Life (2024) Vol. 14, Iss. 9, pp. 1142-1142
Open Access
Zebrafish xenographs in oncology and personalized medicine
Nataliya A. Lunina, D R Safina, Sergey V. Kostrov
Молекулярная биология (2024) Vol. 58, Iss. 3, pp. 363-384
Closed Access
Nataliya A. Lunina, D R Safina, Sergey V. Kostrov
Молекулярная биология (2024) Vol. 58, Iss. 3, pp. 363-384
Closed Access
Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer
Michele Garioni, Lauriane Blukacz, Sandro Nuciforo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Michele Garioni, Lauriane Blukacz, Sandro Nuciforo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Bone mimetic environments support engineering, propagation, and analysis of therapeutic response of patient-derived cells, ex vivo and in vivo
Claudia Paindelli, Vanessa Parietti, Sergio Barrios, et al.
Acta Biomaterialia (2024) Vol. 178, pp. 83-92
Closed Access
Claudia Paindelli, Vanessa Parietti, Sergio Barrios, et al.
Acta Biomaterialia (2024) Vol. 178, pp. 83-92
Closed Access
Zebrafish Xenographs in Oncology and Personalized Medicine
Nataliya A. Lunina, Д. Р. Сафина, Sergey V. Kostrov
Molecular Biology (2024) Vol. 58, Iss. 3, pp. 381-401
Closed Access
Nataliya A. Lunina, Д. Р. Сафина, Sergey V. Kostrov
Molecular Biology (2024) Vol. 58, Iss. 3, pp. 381-401
Closed Access